Asthma - management

Characteristics of a real world cohort of Canadians treated with benralizumab
Stephen G Noorduyn, Mackenzie A Hamilton, Brett Lancaster, Alain Gendron, Lawrence Mbuagbaw, Erika Penz

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3726; DOI: 10.1183/13993003.congress-2021.PA3726
Late Breaking Abstract - Two-year cumulative oral corticosteroid exposure in severe eosinophilic asthma before and after anti-IL-5 therapy
Johannes A Kroes, Sybrand W J Zielhuis, Kim De Jong, Sander W Zielhuis, Eric N Van Roon, Elisabeth H D Bel, Anneke Ten Brinke

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3537; DOI: 10.1183/13993003.congress-2021.PA3537
Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
Aniek Markus, Peter Rijnbeek, Jan Kors, Guy Brusselle, Edward Burn, Daniel Prieto-Alhambra, Katia Verhamme

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3520; DOI: 10.1183/13993003.congress-2021.PA3520
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) in ex-smoker and never smoker patients with inadequately controlled asthma: Post hoc analysis of IRIDIUM study
Huib A.M. Kerstjens, Richard Van Zyl-Smit, Kenneth Chapman, Jorge Maspero, Motoi Hosoe, Ana-Maria Tanase, David Lawrence, Abhijit Pethe, Xu Shu, Karen Mezzi, Peter D'Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3387; DOI: 10.1183/13993003.congress-2021.PA3387
How to improve patient adherence to spacers: Results from a patient survey following introduction of a new spacer designed to help use ‘On the Go’
Jason Suggett, Alison Ellery

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3560; DOI: 10.1183/13993003.congress-2021.PA3560
Mometasone/indacaterol (MF/IND) and mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) and FLU/SAL+tiotropium (TIO) in patients with inadequately controlled asthma: data from the PLATINUM program
Richard Van Zyl-Smit, Kenneth Chapman, Huib Kerstjens, Christian Gessner, Hironori Sagara, Ana-Maria Tanase, Motoi Hosoe, Xu Shu, Abhijit Pethe, David Lawrence, Hanns-Christian Tillmann, Karen Mezzi, Peter D’Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3385; DOI: 10.1183/13993003.congress-2021.PA3385
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study
Jorge Maspero, Huib A. M. Kerstjens, Kenneth R. Chapman, Richard Van Zyl-Smit, Ana-Maria Tanase, David Lawrence, Abhijit Pethe, Karen Mezzi, Peter D'Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3391; DOI: 10.1183/13993003.congress-2021.PA3391
An electronic patient decision aid comparing as-needed budesonide-formoterol combination to regular use of inhaled corticosteroid (ICS) in mild asthma: a rapid-cycle design study
Myriam Gagne, Jeffrey Lam Shin Cheung, Andrew Kouri, Louis-Philippe Boulet, J. Mark Fitzgerald, Allan Grill, Paul M. O'Byrne, Samir Gupta

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3559; DOI: 10.1183/13993003.congress-2021.PA3559
Exploring the psychological impact of the COVID-19 pandemic on adults with asthma: A quantitative study
Kirstie McClatchey, Tracy Jackson, Emma Kinley, Amy Chan, Noelle Morgan, Jessica Rees, Hilary Pinnock

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3562; DOI: 10.1183/13993003.congress-2021.PA3562
CAPTAIN: Relationship between FEV1 reversibility at screening as a continuous variable and treatment response
Guy Brusselle, Neil Barnes, Roland Buhl, Frances Gardiner, Liam G. Heaney, Hiromasa Inoue, Giselle Mosnaim, Alberto Papi, Emilio Pizzichini, Jun Tamaoki, Claus F. Vogelmeier, Agne Zarankaite, Ian Pavord

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3384; DOI: 10.1183/13993003.congress-2021.PA3384

Main menu

User menu

Search

Asthma - management

Pages

Contact us